Tag: AriBio
Firms guide Fosun Pharma’s option agreement with AriBio
HSF, Kewei and Goodwin advise Fosun Pharma on USD240 million AriBio Alzheimer’s drug agreement
HSF, Kewei and Goodwin advise Fosun Pharma on USD240 million AriBio Alzheimer’s drug agreement
Disputes partners must leave their law firms in order to practise as senior advocates. IBLJ asks leading lawyers whether it is time for change
In-house legal teams that adapt now will be better placed for the final judgment after the first ruling on AI training and copyright
Follow us on LinkedIn